Maravai Life Sciences - About the company
Maravai Life Sciences is a public company based in San Diego (United States), founded in 2014 by Carl Hull and Eric Tardif. It operates as a Provides enabling tools and services in the life sciences research and bio-production industries. Maravai Life Sciences has raised an undisclosed amount in funding. The company has 350 active competitors, including 22 funded and 99 that have exited. Its top competitors include companies like Anthem Biosciences, Patheon and Aragen.
Company Details
- Website
- maravai.com
- Email ID
- *****@maravai.com
Key Metrics
Founded Year
2014
Location
San Diego, United States
Stage
Public
Latest Funding Round
Ranked
13th among 350 active competitors
Annual Revenue
$100M - $500M as on Dec 31, 2025
Employee Count
84 as on Sep 30, 2026
Similar Companies
Exit Details
Public
Legal entities associated with Maravai Life Sciences
Maravai Life Sciences is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Maravai Lifesciences Holdings, Inc. CIN: 1823239 , United States, Active | $100M - $500M (As on Dec 31, 2025) | - | - | |
MARAVAI INTERMEDIATE HOLDINGS, LLC CIN: 813611979 , United States, Active | Dec 31, 1999 | - | 581 (As on Dec 31, 2024) | - |
Maravai Life Sciences's IPO details
Maravai Life Sciences got listed on Nov 20, 2020.
Click here to take a look at Maravai Life Sciences's IPO in detail
Sign up to download Maravai Life Sciences' company profile
Maravai Life Sciences's funding and investors
Maravai Life Sciences has raised funding over 1 round. Maravai Life Sciences has 2 institutional investors.
Here is the list of recent funding rounds of Maravai Life Sciences:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Aug 07, 2018 | 4966149 | Conventional Debt | 7460603 | 2519554 | 1804453 | 1971836 |
View details of Maravai Life Sciences's funding rounds and investors
Maravai Life Sciences' founders and board of directors
Founder? Claim ProfileThe founders of Maravai Life Sciences are Carl Hull and Eric Tardif.
Here are the details of Maravai Life Sciences' key team members:
- Carl Hull: Co-Founder & CEO of Maravai Life Sciences.
- Eric Tardif: Co-Founder & President of Maravai Life Sciences.
View details of Maravai Life Sciences's Founder profiles and Board Members
Maravai Life Sciences' employee count trend
Maravai Life Sciences has 84 employees as of Sep 26. Here is Maravai Life Sciences's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Maravai Life Sciences's Competitors and alternates
Top competitors of Maravai Life Sciences include Anthem Biosciences, Patheon and Aragen. Here is the list of Top 10 competitors of Maravai Life Sciences, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Anthem Biosciences 2006, Bengaluru (India), Public | Developer of integrated contract research development and manufacturing services | $35.7M | 76/100 | |
2nd | Patheon 1974, Durham (United States), Acquired | Global CDMO providing integrated drug development, clinical trials, and manufacturing services | $141M | 74/100 | |
3rd | Provider of drug discovery, clinical development, manufacturing, and other services for small molecules | $161M | 69/100 | ||
4th | Provider of contract research and manufacturing services for both small molecules and biologics | $85.9M | 66/100 | ||
5th | Abzena 2001, Cambridge (United Kingdom), Acquired | Provider of antibody discovery, cell line development, and bio analytics services | $67.1M | 66/100 | |
6th | Abingdon Health 2008, York (United Kingdom), Public | Developer of immunoassays for diagnostic purposes | $24.1M | 64/100 | |
7th | Grand River Aseptic Manufacturing 2010, Grand Rapids (United States), Acquired | Aseptic manufacturing CDMO providing fill-finish services for sterile injectables | $16.9M | 58/100 | |
8th | Contract development and manufacturing organization for biologics | - | 58/100 | ||
9th | Daewoong Pharmaceutical 1945, Seoul (South Korea), Public | Developer of therapies for treating gastrointestinal disorders | - | 57/100 | |
10th | Kemwell Biopharma 1980, Bengaluru (India), Acquired | A biologics CDMO providing integrated development and manufacturing | $5.72M | 57/100 | |
13th | Maravai Life Sciences 2014, San Diego (United States), Public | Provides enabling tools and services in the life sciences research and bio-production industries | - | 53/100 |
Looking for more details on Maravai Life Sciences's competitors? Click here to see the top ones
Maravai Life Sciences's Investments and acquisitions
Maravai Life Sciences has not made any investments yet. Maravai Life Sciences has made 5 acquisitions.Here is the list of latest three $acquisitions:
Filter this list
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Jan 28, 2022 | Acquisition | 2007 | San Diego (United States) | |
Mar 17, 2020 | Acquisition | 2012 | Rockville (United States) | |
Jan 03, 2018 | Acquisition | 1987 | Sterling (United States) |
See all acquisitions by Maravai Life Sciences
Reports related to Maravai Life Sciences
Here is the latest report on Maravai Life Sciences's sector:
News related to Maravai Life Sciences
Media has covered Maravai Life Sciences for a total of 9 events in the last 1 year, 5 of them have been about company updates.
•
Maravai LifeSciences Reports Second Quarter 2026 Financial ResultsBusiness Wire•Aug 07, 2026•Maravai Life Sciences
•
Maravai LifeSciences Announces Credit Agreement Refinancing, Extends Maturity to 2032Business Wire•Jun 03, 2026•Maravai Life Sciences
•
First Eagle Investment Management LLC Makes New Investment in Maravai LifeSciences Holdings, Inc. $MRVIMarketBeat•Mar 05, 2026•Maravai Life Sciences, First Eagle Investments
•
Maravai Lifesciences Reports Fourth Quarter and Full Year 2025 Financial ResultsBusiness Wire•Feb 26, 2026•Maravai Life Sciences
•
Marvel Biosciences advances MB-204 toward human trials-Developing a neurosciences platformStockhouse•Jan 23, 2026•Maravai Life Sciences
•
Marwari Catalysts Group Launches Thrive 10.0 for DefenceTech and AgriTech Startups in IndiaThe Tribune•Dec 23, 2025•Maravai Life Sciences
•
Harspring Capital Management LLC Acquires New Shares in Maravai LifeSciences Holdings, Inc. $MRVIMarketBeat•Dec 06, 2025•Maravai Life Sciences
•
Maravai LifeSciences (NASDAQ:MRVI) CEO Acquires $702,689.00 in StockMarketBeat•Nov 19, 2025•Maravai Life Sciences
•
Maravai LifeSciences Reports Third Quarter 2025 Financial ResultsBusiness Wire•Nov 07, 2025•Maravai Life Sciences
•
Philosophy Capital Management LLC Makes New $5.73 Million Investment in Maravai LifeSciences Holdings, Inc. $MRVIMarketBeat•Sep 08, 2025•Philosophy Capital Management, Maravai Life Sciences
Are you a Founder ?
FAQs about Maravai Life Sciences
Explore our recently published companies
- My Boat Life - 2010 founded, Unfunded company
- Enlist - Unfunded company
- Parisienne - France based, Unfunded company
- ScaleDriver - Claremont based, 2016 founded, Unfunded company
- Morling - Unfunded company
- SohAI - Unfunded company